FDA Draft Guidance on PMRs

/ Nov 24, 2019

Bart Cobert highlights the most important changes in the recently revised FDA draft guidance on PMRs.

Read More

Ranitidine – What Happened and What Do We Learn?

/ Oct 31, 2019

Bart Cobert explores several important points to take from the still ongoing signal and safety issue with Renitidine recall.

Read More

Blog Signup